EIT Pharma Closes Oversubscribed $35 Million Series A Round, Led by Propel Bio Partners. Proceeds will advance the company's late-stage infectious disease pipeline.
Amount Raised
$35 Million
Round Type
Series A
KirklandBiotechnologyHealth CareTherapeuticsInvestors
Description
EIT Pharma, Inc. has successfully closed an oversubscribed $35 million Series A financing round led by Propel Bio Partners. The funding aims to support the advancement of EIT Pharma's therapies for infectious diseases, particularly lonafarnib for chronic hepatitis D. In addition, it will aid in FDA review activities and future manufacturing and commercial readiness steps
Quick answer
EIT Pharma raised $35 Million in a Series A round, dated August 31, 2026. Investors: Good Ventures, Arrowtown and Propel Bio Partners. EIT Pharma is based in Kirkland, Washington, United States.
- How much did EIT Pharma raise?
- EIT Pharma raised $35 Million in a Series A round on August 31, 2026.
- Who invested in EIT Pharma?
- Good Ventures, Arrowtown and Propel Bio Partners are named as investors in this round.
- What does EIT Pharma do?
- EIT Pharma is a biotechnology company focusing on developing therapies for infectious diseases.
- Where is EIT Pharma based and how big is it?
- EIT Pharma is based in Kirkland, Washington, United States. Fundz records about 6 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as EIT Pharma that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $7.2M on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Float Bio raised $140K (Pre-Seed) on October 15, 2026.
- seragy holding GmbH raised $13M on October 14, 2026.
- Soufflé Therapeutics raised $135M (Series B) on October 13, 2026.
Who to call at EIT Pharma, and when
A new round usually means EIT Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EIT Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EIT Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EIT Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EIT Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansEIT Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.